Manchester Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Manchester Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-69,535	Closed	-$1.37M	–	1021
2021 Q3	$1.37M	Hold	69,535	–	–	0.19%	75
2021 Q2	$1.64M	Hold	69,535	–	–	0.23%	63
2021 Q1	$1.65M	Hold	69,535	–	–	0.25%	62
2020 Q4	$1.39M	Hold	69,535	–	–	0.22%	71
2020 Q3	$1.45M	Hold	69,535	–	–	0.23%	62
2020 Q2	$1.22M	Hold	69,535	–	–	0.17%	73
2020 Q1	$1.14M	Hold	69,535	–	–	0.18%	65
2019 Q4	$1.43M	Buy	69,535 +27,106	+64%	+$452K	0.16%	72
2019 Q3	$487K	Hold	42,429	–	–	0.06%	156
2019 Q2	$558K	Hold	42,429	–	–	0.07%	142
2019 Q1	$642K	Buy	42,429 +9,429	+29%	+$151K	0.08%	127
2018 Q4	$787K	Hold	33,000	–	–	0.12%	98
2018 Q3	$486K	Hold	33,000	–	–	0.07%	145
2018 Q2	$787K	Hold	33,000	–	–	0.12%	99
2018 Q1	$843K	Buy	33,000 +14,143	+75%	+$337K	0.13%	82
2017 Q4	$348K	Buy	+18,857	New	+$270K	0.05%	153

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Manchester Capital Management's COLL Position: Q4 2021 in Review

Manchester Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2021, closing a stake of 69,535 shares — an estimated $1.37M sold.

Manchester Capital Management first reported a position in COLL in Q4 2017 and held it in 16 quarters. The position peaked at $1.65M in Q1 2021. 159 funds tracked by Wall St. Rank hold COLL as of Q4 2021.

Manchester Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Manchester Capital Management sold 69,535 Collegium Pharmaceutical shares in Q4 2021, an estimated $1.37M.
Manchester Capital Management first reported a position in Collegium Pharmaceutical in Q4 2017 and held it in 16 quarters.
Manchester Capital Management's Collegium Pharmaceutical position peaked at $1.65M in Q1 2021.
159 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2021.

Based on Manchester Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.